Tekla Capital Management’s Repare Therapeutics RPTX Stock Holding History

Tekla Capital Management’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$308K	Hold	29,150	–	–	0.01%	151
2023 Q1	$287K	Hold	29,150	–	–	0.01%	160
2022 Q4	$429K	Hold	29,150	–	–	0.02%	150
2022 Q3	$354K	Hold	29,150	–	–	0.01%	155
2022 Q2	$408K	Hold	29,150	–	–	0.02%	155
2022 Q1	$415K	Hold	29,150	–	–	0.01%	163
2021 Q4	$615K	Buy	+29,150	New	+$687K	0.02%	157

Other funds holding RPTX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return